Lori Leslie in Hackensack, New Jersey

Home New Jersey Hackensack

Lori Leslie has Hematology/oncology as her primary medical specialty. Their primary office is: 30 Prospect Ave in Hackensack, New Jersey.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 201-996-2210 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Columbia University College Of Physicians And Surgeons and graduated in 2009 (around 15 years of experience). They are listed as doing telehealth appointments.

Lori A Leslie Office Phone and Directions

Lori Leslie
Regional Cancer Care Associates Llc
30 Prospect Ave
Hackensack, New Jersey 07601
201-996-2210

Patient Ratings
Please rate your experience with Lori Leslie below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 201-996-2210

Enter a starting address:

Healthcare Info for Lori Leslie

Medical School: Columbia University College Of Physicians And Surgeons
Graduation Year: 2009
The Primary Medical Specialty for Lori Leslie is listed as: Hematology/oncology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 1557519352
NPI #: 1972746394
NPI Created On: 04/15/2009
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RH0000X
License Number:
25MA09658900
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Humana
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Complete blood cell count (red cells, white blood cell, platelets), automated test
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, 30 minutes or less
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
Injection, pegfilgrastim, 6 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,950

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: LORI LESLIE

Third party is a Charity:: No

Record ID:: 788881977

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $3,023

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: LORI LESLIE

Third party is a Charity:: No

Record ID:: 788881979

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $1,515

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788881969

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $750

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788881971

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788881975

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788881973

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017233

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 781017235

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017237

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $2,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 781017239

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Hematology/oncology Professionals in Hackensack

1.
Mark Pascal

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

2.
Richard Scher DO

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

3.
Harry Harper

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

4.
Sukhdeep Kaur

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

5.
Robert Tassan MD

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

6.
Kelley Mowatt Pesce

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group